MTATP6P1: A Promising Drug Target for Energy Production and Cell Signaling

Target Name: MTATP6P1

NCBI ID: G106480796

MTATP6P1

Other Name(s): ATP synthase 6 | MT-ATP6 pseudogene 1 | Mitochondrially encoded ATP synthase 6 pseudogene 1

MTATP6P1: A Promising Drug Target for Energy Production and Cell Signaling

MTATP6P1, also known as ATP synthase 6, is a protein that plays a critical role in the production of ATP, a vital energy compound in all living organisms. TheMTATP6P1 gene was discovered in 2007 and has since been extensively studied to better understand its function in various cellular processes. One of the key findings of these studies is that MTATP6P1 is highly expressed in many tissues and cells, including the brain, heart, and liver. Additionally, MTATP6P1 has been shown to be involved in a number of cellular processes that are important for proper organismal function, including metabolism, cell signaling, and inflammation. As a result, MTATP6P1 has emerged as a promising drug target for a variety of diseases.

TheMTATP6P1 gene is located on chromosome 11q22 and encodes a protein that is composed of 215 amino acids. The protein has a unique structure that is composed of a catalytic active site, a transmembrane region, and an N-terminus. The catalytic active site is the region of the protein that is responsible for catalyzing the conversion of ADP to ATP, a process that is essential for the production of energy in the cell.

MTATP6P1 is a key component of the ATP synthase, a complex of proteins that is responsible for producing the energy-carrying molecule ATP. The ATP synthase is a highly conserved protein that is found in all living organisms, including bacteria, archaea, and eukaryotes. The protein is composed of four subunits, each of which has a distinct function in the production of ATP. The subunit responsible for ATP production is known as subunit A, which is composed of the alpha subunit and the beta subunit. The alpha subunit is responsible for the catalytic activity of the ATP synthase, while the beta subunit is responsible for the structural stability of the protein.

MTATP6P1 is a critical subunit of the ATP synthase, as it is responsible for the catalytic activity of the protein. The catalytic activity of MTATP6P1 is essential for the production of ATP, as it is the region of the protein that is responsible for the conversion of ADP to ATP. In fact, MTATP6P1 is the only subunit of the ATP synthase that is capable of catalyzing the conversion of ADP to ATP. This ability is critical for the production of ATP, which is the energy-carrying molecule that is essential for the functioning of all living organisms.

In addition to its role in the production of ATP, MTATP6P1 is also involved in a number of other cellular processes that are important for proper organismal function. For example, MTATP6P1 has been shown to be involved in the metabolism of carbohydrates, which are the primary source of energy for the cell. MTATP6P1 has been shown to play a role in the breakdown of glucose, which is a critical source of energy for the brain and other tissues.

MTATP6P1 is also involved in cell signaling, which is the process by which cells communicate with one another to coordinate their activities. MTATP6P1 has been shown to be involved in a number of signaling pathways that are important for proper organismal function. For example, MTATP6P1 has been shown to be involved in the signaling pathway that is responsible for regulating cell growth and differentiation. Additionally, MTATP6P1 has been shown to be involved in the signaling pathway that is responsible for regulating cell survival and apoptosis, which is the process by which cells respond to

Protein Name: MT-ATP6 Pseudogene 1

The "MTATP6P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTATP6P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets